JPH07505875A - α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途 - Google Patents

α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途

Info

Publication number
JPH07505875A
JPH07505875A JP5518139A JP51813993A JPH07505875A JP H07505875 A JPH07505875 A JP H07505875A JP 5518139 A JP5518139 A JP 5518139A JP 51813993 A JP51813993 A JP 51813993A JP H07505875 A JPH07505875 A JP H07505875A
Authority
JP
Japan
Prior art keywords
formula
group
compounds
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5518139A
Other languages
English (en)
Japanese (ja)
Inventor
バーンスタイン，ピーター・ロバート
ショウ，アンドリュー
シェンヴィ，アショックマー・ビカッパ
トーマス，ロイストン・マーティン
ワーナー，ピーター
ウォラニン，ドナルド・ジョン
Original Assignee
ゼネカ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929208387A external-priority patent/GB9208387D0/en
Priority claimed from GB929217366A external-priority patent/GB9217366D0/en
Application filed by ゼネカ・リミテッド filed Critical ゼネカ・リミテッド
Publication of JPH07505875A publication Critical patent/JPH07505875A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP5518139A 1992-04-16 1993-04-15 α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途 Pending JPH07505875A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929208387A GB9208387D0 (en) 1992-04-16 1992-04-16 Heterocyclic derivatives
GB9208387.2 1992-04-16
GB9217366.5 1992-08-14
GB929217366A GB9217366D0 (en) 1992-08-14 1992-08-14 Heterocyclic derivatives
PCT/GB1993/000796 WO1993021213A1 (fr) 1992-04-16 1993-04-15 Peptides d'acide alpha-aminoboronique et leur utilisation comme inhibiteurs d'elastase

Publications (1)

Publication Number Publication Date
JPH07505875A true JPH07505875A (ja) 1995-06-29

Family

ID=26300738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5518139A Pending JPH07505875A (ja) 1992-04-16 1993-04-15 α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途

Country Status (5)

Country Link
EP (1) EP0636144A1 (fr)
JP (1) JPH07505875A (fr)
AU (1) AU4077193A (fr)
CA (1) CA2133658A1 (fr)
WO (1) WO1993021213A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US5756466A (en) 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) * 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
NZ500352A (en) 1997-04-14 2001-10-26 Cor Therapeutics Inc Cyclic diaza selective factor Xa inhibitors
US6204268B1 (en) 1997-04-14 2001-03-20 Cor Therapeutics, Inc Selective factor Xa inhibitors
AU747531B2 (en) 1997-04-14 2002-05-16 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US7122627B2 (en) 1999-07-26 2006-10-17 Bristol-Myers Squibb Company Lactam inhibitors of Hepatitis C virus NS3 protease
WO2001007407A1 (fr) * 1999-07-26 2001-02-01 Bristol-Myers Squibb Pharma Company Inhibiteurs lactame de la protease ns3 du virus de l'hepatite c
WO2013084199A1 (fr) * 2011-12-07 2013-06-13 Universidade De Lisboa Hétérocycles de bore utiles en tant que nouveaux inhibiteurs de l'élastase des neutrophiles chez l'homme
JP6268014B2 (ja) * 2014-03-20 2018-01-24 富士フイルム株式会社 サラシノールの製造に有用な化合物およびそれらの製造法、サラシノールの製造法、ジオール基の保護方法および脱保護方法、並びにジオール基の保護剤
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
WO2021209740A1 (fr) 2020-04-16 2021-10-21 Mereo Biopharma 4 Limited Procédés impliquant l'alvélestat, un inhibiteur de l'élastase des neutrophiles, pour le traitement d'une infection à coronavirus
EP4419102A1 (fr) 2021-10-20 2024-08-28 Mereo Biopharma 4 Limited Inhibiteurs de l'élastase neutrophile utilisés dans le traitement de la fibrose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315574A3 (fr) * 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Inhibiteurs de la rénine
US4963655A (en) * 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides

Also Published As

Publication number Publication date
EP0636144A1 (fr) 1995-02-01
AU4077193A (en) 1993-11-18
WO1993021213A1 (fr) 1993-10-28
CA2133658A1 (fr) 1993-10-28

Similar Documents

Publication Publication Date Title
JPH07505875A (ja) α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途
US5736535A (en) 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase
JP3415151B2 (ja) Ｈｌｅ阻害活性を有するラクタムペプチド
JP3491690B2 (ja) エラスターゼ阻害剤としてのピリミジニルアセトアミド
EP0509769B1 (fr) Amides hétérocycliques ayant une activité inhibante de HLE
EP0630382B1 (fr) Dipeptides de lactame a activite d'inhibition de l'elastase leucocytaire humaine
JPWO1998009949A1 (ja) 新規アセトアミド誘導体およびプロテアーゼ阻害剤
JP2001504810A (ja) 選択的第Ｘａ因子阻害剤
JP2001518513A (ja) ペプチド含有α−ケトアミドのシステインおよびセリンプロテアーゼ阻害剤
JPH10513173A (ja) ヒト白血球エラスターゼの阻害剤として有用なプロリン誘導体
AU669545B2 (en) Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
BR112019012515A2 (pt) antagonistas de integrina
US7196112B2 (en) Cell adhesion inhibitors
JP2001089448A (ja) アミド誘導体
JPH09508902A (ja) ヒト白血球エラスターゼの阻害剤としてのジアステレオマー純粋なトリフルオロメチルケトンペプチド誘導体
WO1999041277A1 (fr) Nouveau derive d'acetamide et son utilisation
JPH08501099A (ja) 血小板凝集阻害剤
US5270301A (en) Fluoro-amide derivatives
JP2005521641A (ja) 第ｘａ因子阻害剤としての２−（３−スルホニルアミノ−２−オキソピロリジン−１−イル）プロパンアミド
JPS61229897A (ja) 新規ヌクレオシド化合物
US5723442A (en) Peptide derivatives
HU228917B1 (hu) Spiroimidazolidin származékok, elõállításuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
JPWO1999041277A1 (ja) 新規アセトアミド誘導体及びその用途
CN101522629B (zh) 2-氨基羰基-吡啶衍生物